Bengaluru-based Bodycraft has secured ₹120 crore in Series A funding led by Singularity AMC to open 30 new clinic-salon outlets. The company plans to use the capital to scale its hybrid service model and upgrade technology. As a private entity, this deal highlights the growing institutional interest in India’s organized beauty and aesthetic services market.
What Happened
Bodycraft, a Bengaluru-based firm operating in the beauty, wellness, and medical aesthetics space, has raised ₹120 crore in its Series A funding round led by Singularity AMC. This is the first major institutional capital infusion for the company in nearly nine years. The firm, founded in 1997, currently runs 67 outlets across more than 10 cities, consisting of 33 clinics and 34 salons.
The capital is earmarked for a significant expansion, with plans to open 30 new locations. The company utilizes a hybrid business model, combining company-owned, company-operated (COCO) outlets with franchise-owned, franchise-operated (FOFO) setups to scale its national footprint while managing capital expenditure.
Why Private Equity Is Entering This Space
The Indian beauty and wellness sector has historically been dominated by unorganized, small-scale players. However, changing consumer preferences are driving a shift toward organized, branded services that offer standardized treatments and medical-grade aesthetics. Investors are increasingly betting on companies that can bridge the gap between traditional salon services and specialized dermatological care.
The move by Singularity AMC reflects a broader trend of private capital seeking to formalize fragmented service industries. For Bodycraft, the strategy involves not just expanding its physical footprint but also investing in AI-driven operations and advanced clinical equipment to increase the value proposition of its service offerings.
The Business Reality Check
While Bodycraft is not a publicly listed company, its expansion plans offer context for the broader aesthetic and wellness sector. Listed peers like Kaya Limited operate in the specialized skincare and aesthetic dermatology space, providing investors with a benchmark for how such models function in public markets.
Companies in this sector often face high operational costs, as they require significant investment in skilled professionals, advanced medical machinery, and real estate in high-traffic retail areas. Maintaining consistent service quality across 30 new locations while managing the mix of company-owned and franchise outlets will be the key test for the management team.
Operational and Execution Risks
The primary risk for firms in this sector is the ability to execute aggressive expansion without eroding profit margins. As the company scales, it will need to ensure that the clinical division—which is a key revenue driver—maintains strict standards to retain customer trust. Any failure in service quality or a delay in the commissioning of new clinics can lead to cost overruns and lower-than-expected returns on invested capital.
Furthermore, the sector is highly competitive. Aside from organized chains, the company competes with thousands of independent premium salons and local dermatologists, which keeps pricing pressure high. The company's success will depend on its ability to offer distinct, high-value treatments that differentiate it from smaller, lower-cost competitors.
What Investors Should Track
Although Bodycraft remains private, investors interested in the aesthetic and wellness sector may track several key developments in the industry. These include the pace of new outlet openings, the stability of operating margins as the firm expands, and the adoption rate of its new clinical technology. For companies in this space, monitoring the ability to balance rapid physical growth with the maintenance of a strong, profitable service brand will be essential for evaluating the long-term viability of the hybrid clinic-salon model.